Havlane



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 24.6%
Depression 14.3%
Drug Use For Unknown Indication 13.8%
Insomnia 7.1%
Anxiety 6.7%
Prostatic Disorder 6.3%
Ill-defined Disorder 5.4%
Hiv Infection 3.6%
Schizophrenia, Paranoid Type 3.6%
Hypertension 3.1%
Hiv Test Positive 2.2%
Hepatitis C 1.3%
Hypotension 1.3%
Schizophrenia 1.3%
Dysuria 0.9%
Epilepsy 0.9%
Pain In Extremity 0.9%
Parkinsonism 0.9%
Renal Failure Chronic 0.9%
Secondary Parkinsonism 0.9%
Somnolence 12.2%
Weight Decreased 9.8%
Orthostatic Hypotension 7.3%
Premature Baby 7.3%
Subileus 7.3%
Agranulocytosis 4.9%
Cytolytic Hepatitis 4.9%
Insomnia 4.9%
Malaise 4.9%
Pericarditis 4.9%
Pollakiuria 4.9%
Suicide Attempt 4.9%
Thrombocytopenia 4.9%
Dysuria 2.4%
Electroencephalogram Abnormal 2.4%
Femoral Neck Fracture 2.4%
Grand Mal Convulsion 2.4%
Hepatocellular Injury 2.4%
Joint Sprain 2.4%
Ligament Sprain 2.4%
Concomitant
Product Used For Unknown Indication 27.3%
Depression 10.2%
Drug Use For Unknown Indication 8.0%
Hepatitis C 7.0%
Schizophrenia 5.4%
Pain 5.1%
Anxiety 4.8%
Insomnia 4.8%
Gastric Cancer 3.2%
Major Depression 2.7%
Metastatic Gastric Cancer 2.4%
Psoriasis 2.4%
Hypertension 2.1%
Influenza Like Illness 2.1%
Premedication 2.1%
Sleep Disorder 2.1%
Thrombosis Prophylaxis 2.1%
Type 2 Diabetes Mellitus 2.1%
Atrial Fibrillation 1.9%
Bacterial Infection 1.9%
Pulmonary Embolism 15.3%
General Physical Health Deterioration 8.5%
Vomiting 6.8%
Cystitis 5.1%
Drug Interaction 5.1%
Pancytopenia 5.1%
Rash 5.1%
Suicide Attempt 5.1%
Weight Decreased 5.1%
Weight Increased 5.1%
Acute Coronary Syndrome 3.4%
Asthma 3.4%
Cholecystitis 3.4%
Confusional State 3.4%
Idiopathic Urticaria 3.4%
Inappropriate Schedule Of Drug Administration 3.4%
International Normalised Ratio Increased 3.4%
Intestinal Obstruction 3.4%
Ischaemic Stroke 3.4%
Jaundice Cholestatic 3.4%